HER2+ Breast Cancer Pilot Study

February 9, 2023 Blood was drawn from 16 breast cancer patients and enriched for Circulating Tumor Cells (CTCs) using LiquidScan. Isolated cells were analyzed for HER2 positivity [Read More...]

HER2+ Breast Cancer Pilot Study2023-03-22T10:49:30-07:00
Go to Top